New hope for Tough-to-Treat leukemia: experimental drug DFP-10917 tested in Late-Stage trial
Disease control
Terminated
This study tested a new drug called DFP-10917 in adults with acute myeloid leukemia (AML) that had returned or not responded after 2 to 4 prior treatments. Participants received either DFP-10917 or one of several standard chemotherapy combinations. The goal was to see if DFP-1091…
Phase: PHASE3 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC